BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23246108)

  • 1. Study on bladder cancer susceptibility and genetic polymorphisms of XPC, XPG, and CYP in smokers and non-smokers.
    Wen H; Feng CC; Fang ZJ; Xia GW; Jiang HW; Xu G; Huang XD; Ding Q
    Actas Urol Esp; 2013 May; 37(5):259-65. PubMed ID: 23246108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk.
    Liu Y; Wang H; Lin T; Wei Q; Zhi Y; Yuan F; Song B; Yang J; Chen Z
    Oncol Rep; 2012 Jul; 28(1):337-45. PubMed ID: 22505326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma].
    Li LM; Zeng XY; Ji L; Fan XJ; Li YQ; Hu XH; Qiu XQ; Yu HP
    Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):271-5. PubMed ID: 20460046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
    Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1).
    Narter KF; Ergen A; Agaçhan B; Görmüs U; Timirci O; Isbir T
    Anticancer Res; 2009 Apr; 29(4):1389-93. PubMed ID: 19414392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
    Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
    Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk.
    García-Closas M; Malats N; Real FX; Welch R; Kogevinas M; Chatterjee N; Pfeiffer R; Silverman D; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Chanock S; Yeager M; Rothman N
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):536-42. PubMed ID: 16537713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai.
    Wen H; Ding Q; Fang ZJ; Xia GW; Fang J
    Int Urol Nephrol; 2009 Dec; 41(4):855-64. PubMed ID: 19350405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer.
    Jeon HS; Kim KM; Park SH; Lee SY; Choi JE; Lee GY; Kam S; Park RW; Kim IS; Kim CH; Jung TH; Park JY
    Carcinogenesis; 2003 Oct; 24(10):1677-81. PubMed ID: 12869423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
    Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
    Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
    Gu J; Zhao H; Dinney CP; Zhu Y; Leibovici D; Bermejo CE; Grossman HB; Wu X
    Clin Cancer Res; 2005 Feb; 11(4):1408-15. PubMed ID: 15746040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort.
    Fontana L; Bosviel R; Delort L; Guy L; Chalabi N; Kwiatkowski F; Satih S; Rabiau N; Boiteux JP; Chamoux A; Bignon YJ; Bernard-Gallon DJ
    Anticancer Res; 2008; 28(3B):1853-6. PubMed ID: 18630471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?
    Gangwar R; Ahirwar D; Mandhani A; Mittal RD
    Mutat Res; 2009; 680(1-2):56-63. PubMed ID: 19815090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in DNA repair and metabolic genes in bladder cancer.
    Sanyal S; Festa F; Sakano S; Zhang Z; Steineck G; Norming U; Wijkström H; Larsson P; Kumar R; Hemminki K
    Carcinogenesis; 2004 May; 25(5):729-34. PubMed ID: 14688016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients.
    Sun X; Li F; Sun N; Shukui Q; Baoan C; Jifeng F; Lu C; Zuhong L; Hongyan C; YuanDong C; Jiazhong J; Yingfeng Z
    Lung Cancer; 2009 Aug; 65(2):230-6. PubMed ID: 19157633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
    Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
    Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients.
    Li Y; Liu Z; Liu H; Wang LE; Onodera H; Suzuki A; Suzuki K; Wadhwa R; Elimova E; Sudo K; Shiozaki H; Estrella J; Lee JS; Song S; Tan D; Ajani JA; Wei Q
    Carcinogenesis; 2014 Sep; 35(9):2031-8. PubMed ID: 24990617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle-invasive neoplasms of the urinary bladder.
    Sakano S; Kumar R; Larsson P; Onelöv E; Adolfsson J; Steineck G; Hemminki K
    BJU Int; 2006 Apr; 97(4):847-51. PubMed ID: 16536785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.